ASDr. Ahmed ShihabConsultant Anesthesiologist – Baghdad عربي

Acute Kidney Injury and Renal Replacement Therapy in Intensive Care

Topic notes · Intensive Care · Renal, fluids and metabolism

Acute kidney injury is a frequent and life-threatening clinical syndrome in intensive care patients, requiring accurate and rapid diagnosis based on international criteria. This article aims to review the KDIGO classification, the causes of renal failure, and the indications for urgent dialysis, with a focus on the role of CRRT and regional anticoagulation.

KDIGO classification and the causes of renal failure

The KDIGO classification is used to determine the severity of kidney injury by tracking creatinine and urine output; stage one includes a rise in creatinine of 1.5 times the baseline value or an increase of ≥0.3 mg/dL within 48 hours, or urine output <0.5 mL/kg/h for ≥6 hours. Stage two occurs when creatinine doubles or oliguria persists (<0.5 mL/kg/h) for ≥12 hours, whereas stage three is defined by a rise in creatinine of 3 times or a fall in urine output below 0.3 mL/kg/h for ≥24 hours, or complete anuria for ≥12 hours. The causes are divided into prerenal causes resulting from hypovolaemia (such as haemorrhage, burns or diarrhoea), impaired cardiac function or vasodilatation (as in sepsis and liver cirrhosis), and intrinsic causes such as acute tubular necrosis, interstitial nephritis associated with NSAIDs, and vascular and glomerular injuries.

Indications for urgent dialysis and the preference for CRRT

The indications for urgent dialysis are summarised by the AEIOU rule, and include acidosis refractory to bicarbonate, electrolyte disturbances, most notably refractory hyperkalaemia, which is the most common cause, poisoning with dialysable substances such as aspirin, lithium, methanol and ethylene glycol, fluid overload accompanied by hypoxaemia and oliguria, in addition to uraemia accompanied by pericarditis, encephalopathy or bleeding. When comparing dialysis techniques, continuous renal replacement therapy (CRRT) is distinguished by providing better haemodynamic stability, safely removing larger volumes of fluid, and superior control of acidosis with fewer sharp fluctuations in intracranial pressure (ICP fluctuations).

Regional citrate anticoagulation in CRRT

Regional citrate anticoagulation is an effective option within the filtration circuit; citrate chelates calcium inside the filter, which limits clotting of the circuit and reduces the risks of systemic bleeding. Its major clinical benefit stands out in patients with active bleeding or heparin-induced thrombocytopenia. However, great caution should be exercised in severe liver failure because citrate metabolism depends on the liver, with a need for close monitoring and follow-up for the risks of hypocalcaemia and acid-base disturbances.

Key points
  • KDIGO stage one is diagnosed by a rise in creatinine of 1.5 times or urine output below 0.5 mL/kg/h for at least 6 hours.
  • The causes of renal failure range from prerenal, such as hypovolaemia and sepsis, to intrinsic renal causes such as drug-induced interstitial nephritis and tubular necrosis.
  • Refractory hyperkalaemia is the most common indication among the five indications for urgent dialysis (AEIOU).
  • CRRT is superior to intermittent dialysis in circulatory stability, fluid removal and reducing fluctuations in intracranial pressure.
  • Citrate anticoagulation depends on chelating calcium in the filter and requires great caution in liver failure to reduce the risk of hypocalcaemia.

Sources

  • Critical Care Secrets, 6th ed., p. 302
  • Critical Care Secrets, 6th ed., pp. 302–303
  • Critical Care Secrets, 6th ed., p. 308
  • Critical Care Secrets, 6th ed., p. 310
  • Annual Update in Intensive Care and Emergency Medicine 2022, pp. 214–215

Test yourself: 9 questions on this topic and many more →

Educational content for healthcare staff and students. It does not replace clinical judgement or your hospital protocol; check any dose against the reference and local guidance before use.